Welcome to our dedicated page for ReposiTrak SEC filings (Ticker: TRAK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for ReposiTrak, Inc. (NYSE: TRAK), a Nevada corporation that operates a cloud-based food traceability, compliance and supply chain data platform. Through these filings, investors can review how the company reports its financial results, corporate actions and governance matters in accordance with SEC requirements.
ReposiTrak’s recent Form 8-K filings include disclosures about quarterly cash dividend declarations on its common stock, authorization of a 10b5-1 share repurchase program under a broader repurchase authorization, earnings releases for fiscal quarters and years, and the results of its annual meeting of stockholders. These current reports also reference attached press releases and earnings call transcripts that provide additional detail on financial performance, capital allocation and operational commentary.
In addition to current reports, ReposiTrak files periodic reports such as Form 10-K annual reports and Form 10-Q quarterly reports, which contain audited or reviewed financial statements, management’s discussion and analysis, risk factor disclosures and information on its business, including its focus on food traceability, regulatory compliance and supply chain solutions delivered through cloud-based applications.
Stock Titan’s filings page is designed to surface these documents as they are made available on EDGAR and to pair them with AI-powered summaries that explain the key points in accessible language. Users can quickly identify items such as dividend announcements, share repurchase authorizations, earnings results and shareholder meeting outcomes, and then drill into the underlying SEC reports for more detail. This same interface can also be used to monitor insider and executive transactions reported on forms such as Form 4, as those become available for ReposiTrak insiders.
ReposiTrak (TRAK) disclosed an insider transaction on a Form 4. CEO, Director and 10% owner Randall K. Fields reported a sale of 7,500 shares of common stock on 11/03/2025 at a weighted average price of $15.0126, executed under a Rule 10b5-1 trading plan to meet charitable commitments. The filing notes the shares were sold in multiple trades between $15.00 and $15.10. Following the transaction, reported holdings include 3,683,955 shares direct and various indirect positions, including 20,000 by RK Fields Charitable 2022, LLC.
ReposiTrak (TRAK) disclosed insider transactions by Randall K. Fields, its Chief Executive Officer, director, and 10% owner. Acting through RK Fields Charitable 2022, LLC under a Rule 10b5-1 trading plan, he sold a total of 7,500 shares across three days: 3,800 shares on 10/28/2025 at a weighted average price of $15.2786, 1,000 shares on 10/29/2025 at $15.1774, and 2,700 shares on 10/30/2025 at $14.9978. The plan was established to meet charitable commitments.
Following the reported transactions, beneficial holdings included 27,500 shares indirectly by RK Fields Charitable 2022, LLC and 3,683,955 shares held directly, with additional indirect holdings reported through Riverview Financial Corp., his spouse, and Fields Management, Inc., as well as Series B Preferred Stock holdings.
ReposiTrak, Inc. (TRAK) CEO, Director, and 10% owner Randall K. Fields reported a sale of common stock on 10/20/2025. The filing shows a disposition of 7,500 shares coded “S,” executed under a Rule 10b5-1 trading plan established to meet charitable commitments.
The weighted average sale price was $15.467, with individual trades ranging from $14.80 to $15.21. Following the reported transaction, the filing lists 35,000 shares indirectly held by RK Fields Charitable 2022, LLC.
Additional beneficial holdings disclosed include 3,683,955 shares (direct), 615,260 shares indirectly by Riverview Financial Corp., 30,667 shares indirectly by spouse, and 333,643 shares indirectly by Fields Management, Inc. The filing also lists Series B Preferred Stock positions: 289,673 shares indirectly by Riverview Financial Corp. and 6,721 shares indirectly by spouse.
ReposiTrak (TRAK) disclosed that CEO, director and 10% owner Randall K. Fields sold a total of 7,500 shares of common stock on October 14–15, 2025 under a Rule 10b5-1 trading plan executed through RK Fields Charitable 2022, LLC, established to help meet charitable commitments.
Transactions included: 1,500 shares at a weighted average price of $14.7377 on 10/14, 1,640 shares at $14.4227 on 10/14, and 4,360 shares at $14.4227 on 10/15. Following these sales, the filing shows 42,500 shares held indirectly by the charitable LLC and 3,683,955 shares held directly, alongside additional indirect holdings through affiliated entities.
Randall K. Fields, who serves as Chief Executive Officer, Director and a >10% owner of ReposiTrak, Inc. (TRAK), reported a sale of 7,500 shares of common stock on
The sale was executed automatically to satisfy charitable commitments and occurred across multiple transactions with prices ranging from
Randall K. Fields, CEO, director and 10% owner of ReposiTrak, Inc. (TRAK), reported multiple sales of Common Stock under an existing Rule 10b5-1 trading plan established to meet charitable commitments. The Form 4 shows five reported dispositions executed on 09/29/2025, 09/30/2025 and 10/01/2025 totaling 7,500 shares sold at weighted-average prices ranging from approximately $14.91 to $16.97 per share. The sales were made indirectly by RK Fields Charitable 2022, LLC pursuant to the trustee role in a charitable remainder unitrust. The filing lists significant remaining holdings held directly and indirectly, including large direct and indirect positions in common stock and Series B preferred stock across related entities and spouse holdings.
ReposiTrak, Inc. (TRAK) reports operational and financial disclosures in its Form 10-K. The company states it has not identified any cybersecurity threats that have materially affected or are reasonably likely to materially affect its business, and it maintains employee reporting procedures and quarterly Audit Committee reviews of cybersecurity policies. Contract asset balances at June 30, 2025 include a current contract asset of $428,585. The company reports zero bank debt and a revolving credit facility balance of zero as of June 30, 2025, while maintaining cash/liquid assets above previously required covenant levels. Common stock details show 336,098 and 616,470 shares issued and outstanding at June 30, 2025 and 2024 (par $0.01), and total common shares outstanding of 18,282,805 at June 30, 2025. The company disclosed lease arrangements with no future lease commitments under a prior lease and a month-to-month office lease treated as short-term. It disclosed stock plans (2023 Plan and ESPP), warrant activity, and preferred stock designations including 700,000 Series B Preferred with dividend rates of 7% (cash) or 9% (paid-in-kind) and a redemption price of $10.70 per share. The company repurchased 2,131,384 common shares at an average of $6.20 and has $7,792,173 remaining under its repurchase program as of June 30, 2025.
Randall K. Fields, CEO, Director and 10% owner of ReposiTrak, Inc. (TRAK), reported multiple dispositions of company stock on 09/22/2025 and 09/23/2025. The report shows sales of 3,000 shares on 09/22/2025 at a weighted average price of $17.5775 and 4,000 shares on 09/23/2025 at a weighted average price of $17.3856, executed pursuant to a Rule 10b5-1 trading plan established by the reporting person as trustee of a charitable unitrust.
The Form 4 discloses significant other holdings and dispositions: a reported disposition of 3,683,955 shares of common stock, direct ownership of 615,260 shares indirectly, and various indirect holdings through Riverview Financial Corp., spouse, Fields Management, Inc., and a charitable LLC. Footnotes state the sales occurred in multiple transactions and provide price ranges for each weighted average.
ReposiTrak, Inc. declared a quarterly cash dividend of $0.02 per share, equivalent to $0.08 annually, on its common stock. The dividend was announced on September 19, 2025, will be payable on or about November 14, 2025, and applies to holders of record as of September 30, 2025. The company attached a press release as Exhibit 99.1 to this Current Report. The filing states that the exhibit and related Item 8.01 disclosure are furnished, not filed, under the Exchange Act.
FAQ
What is the current stock price of ReposiTrak (TRAK)?
What is the market cap of ReposiTrak (TRAK)?
